Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
39.83
+2.14 (5.68%)
At close: May 7, 2026, 4:00 PM EDT
39.76
-0.07 (-0.18%)
After-hours: May 7, 2026, 7:09 PM EDT
Sutro Biopharma Employees
Sutro Biopharma had 137 employees as of December 31, 2025. The number of employees decreased by 173 or -55.81% compared to the previous year.
Employees
137
Change
-173
Growth
-55.81%
Revenue / Employee
$748,058
Profits / Employee
-$1,394,788
Market Cap
659.90M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 137 | -173 | -55.81% |
| Sep 30, 2025 | 178 | -128 | -41.83% |
| Jun 30, 2025 | 244 | -60 | -19.74% |
| Mar 31, 2025 | 269 | -31 | -10.33% |
| Dec 31, 2024 | 310 | 8 | 2.65% |
| Sep 30, 2024 | 306 | 8 | 2.68% |
| Jun 30, 2024 | 304 | 7 | 2.36% |
| Mar 31, 2024 | 300 | 8 | 2.74% |
| Dec 31, 2023 | 302 | 24 | 8.63% |
| Sep 30, 2023 | 298 | 39 | 15.06% |
| Jun 30, 2023 | 297 | 55 | 22.73% |
| Mar 31, 2023 | 292 | 58 | 24.79% |
| Dec 31, 2022 | 278 | 54 | 24.11% |
| Sep 30, 2022 | 259 | 41 | 18.81% |
| Jun 30, 2022 | 242 | 38 | 18.63% |
| Mar 31, 2022 | 234 | 39 | 20.00% |
| Dec 31, 2021 | 224 | 33 | 17.28% |
| Sep 30, 2021 | 218 | 36 | 19.78% |
| Jun 30, 2021 | 204 | 27 | 15.25% |
| Mar 31, 2021 | 195 | 18 | 10.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Arvinas | 246 |
| ProKidney | 231 |
| CorMedix | 191 |
| Cabaletta Bio | 156 |
| Prime Medicine | 146 |
| enGene Therapeutics | 82 |
| Prothena Corporation | 67 |
| AgomAb Therapeutics NV | 58 |
STRO News
- 7 days ago - Sutro Biopharma initiated with an Outperform at Mizuho - TheFly
- 14 days ago - Sutro Biopharma price target raised to $41 from $35 at Citizens - TheFly
- 18 days ago - Sutro Biopharma presents preclinical data across its pipeline of ADCs - TheFly
- 20 days ago - Sutro Biopharma price target raised to $35 from $23 at Citizens - TheFly
- 24 days ago - Sutro Biopharma management to meet with Citizens - TheFly
- 4 weeks ago - Sutro Biopharma initiated with an Outperform at Leerink - TheFly
- 6 weeks ago - Sutro Biopharma price target raised to $55 from $51 at Deutsche Bank - TheFly
- 6 weeks ago - Sutro Biopharma upgraded to Buy from Neutral at H.C. Wainwright - TheFly